{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:40:31Z","timestamp":1792546831000,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2016-1778"],"award-info":[{"award-number":["TMA2016-1778"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malaria is a major cause of morbidity and mortality in pediatrics in malaria endemic areas. Artemisinin-based combination therapies (ACTs) are the drugs of choice for malaria management particularly across malaria-endemic countries. This systematic review and meta-analysis was performed to assess efficacy and safety of ACTs for uncomplicated malaria in pediatric populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A body of evidence was searched for published ACT trials until March 06, 2020. The search was focused on efficacy and safety studies of ACTs for uncomplicated malaria in pediatrics. PubMed library was searched using best adapted search terms after multiple trials. References were exported to the endnote library and then to Covidence for screening. Data was extracted using the Covidence platform. The per-protocol analysis report for the efficacy and the intention-to-treat analysis for the safety were synthesized. Met-analysis was carried using Open Meta-Analyst software. Random effects model was applied and the heterogeneity of studies was evaluated using I\n                      <jats:sup>2<\/jats:sup>\n                      statistic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nineteen studies were included in the final analysis. Overall, crude, PCR-corrected\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      malaria treatment success rate was 96.3 and 93.9% for day 28 and 42, respectively. In the subgroup analysis, PCR-corrected adequate clinical and parasitological response (ACPR) of dihydroartemisinin-piperaquine (DP) was 99.6% (95% CI: 99.1 to 100%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u20090%; 4 studies) at day 28 and 99.6% (95% CI of 99 to 100%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u20090%; 3 studies) at day 42. Nine studies reported ACT related adverse drug reactions (ADR) (8.3%, 356\/4304). The reported drug related adverse reactions ranged from 1.8% in DP (two studies) to 23.3% in artesunate-pyronaridine (AP). Gastrointestinal symptoms were the most common ACT related adverse effects, and all ADRs were reported to resolve spontaneously.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      ACTs demonstrated a high crude efficacy and tolerability against\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      . The high treatment success and tolerability with low heterogeneity conferred by DP has implication for policy makers who plan the use of ACTs for uncomplicated falciparum malaria treatment in pediatrics.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06018-6","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T09:06:05Z","timestamp":1617786365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Workineh","family":"Shibeshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Alemkere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assefa","family":"Mulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Engidawork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"6018_CR1","volume-title":"World Malaria Report","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. World Malaria Report. 2018 Available from: https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/en\/."},{"key":"6018_CR2","volume-title":"A global stratagy for malaria control","author":"World Health Orgnanization","year":"1993","unstructured":"World Health Orgnanization. A global stratagy for malaria control. 1993 Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/41785."},{"key":"6018_CR3","volume-title":"Antimalarial drug combination therapy : report of a WHO technical consultation","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Antimalarial drug combination therapy : report of a WHO technical consultation, 2001 Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/66952."},{"key":"6018_CR4","volume-title":"Artemisinin resistance and artemisinin-based combination therapy efficacy: status report","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Artemisinin resistance and artemisinin-based combination therapy efficacy: status report 2018 Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/274362."},{"issue":"1","key":"6018_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12936-018-2265-x","volume":"17","author":"I Adam","year":"2018","unstructured":"Adam I, Ibrahim Y, Gasim GI. Efficacy and safety of artemisinin-based combination therapy for uncomplicated plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis. Malar J. 2018;17(1):110.","journal-title":"Malar J"},{"issue":"1","key":"6018_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-016-0716-1","volume":"14","author":"L Denoeud-Ndam","year":"2016","unstructured":"Denoeud-Ndam L, Dicko A, Baudin E, Guindo O, Grandesso F, Diawara H, et al. Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger. BMC Med. 2016;14(1):167.","journal-title":"BMC Med"},{"issue":"3","key":"6018_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/cid\/cix336","volume":"65","author":"MM Ippolito","year":"2017","unstructured":"Ippolito MM, Johnson J, Mullin C, Mallow C, Morgan N, Wallender E, et al. The relative effects of Artemether-lumefantrine and non-artemisinin Antimalarials on gametocyte carriage and transmission of plasmodium falciparum: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(3):486\u201394.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"6018_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1473-3099(09)70327-5","volume":"10","author":"F Kurth","year":"2010","unstructured":"Kurth F, Belard S, Adegnika AA, Gaye O, Kremsner PG, Ramharter M. Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. Lancet Infect Dis. 2010;10(2):125\u201332.","journal-title":"Lancet Infect Dis"},{"key":"6018_CR9","first-page":"CD007483","volume":"3","author":"D Sinclair","year":"2009","unstructured":"Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009;3:CD007483.","journal-title":"Cochrane Database Syst Rev"},{"key":"6018_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1475-2875-11-147","volume":"11","author":"S Whegang Youdom","year":"2012","unstructured":"Whegang Youdom S, Samson A, Basco LK, Thalabard JC. Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations. Malar J. 2012;11:147.","journal-title":"Malar J"},{"key":"6018_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","volume":"13","author":"WorldWide Antimalarial Resistance Network Lumefantrine PKPDSG","year":"2015","unstructured":"WorldWide Antimalarial Resistance Network Lumefantrine PKPDSG. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Med. 2015;13:227.","journal-title":"BMC Med"},{"key":"6018_CR12","first-page":"CD010927","volume":"1","author":"B Zani","year":"2014","unstructured":"Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-piperaquine for treating uncomplicated plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014;1:CD010927.","journal-title":"Cochrane Database Syst Rev"},{"key":"6018_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12936-015-0649-8","volume":"14","author":"A Shayo","year":"2015","unstructured":"Shayo A, Buza J, Ishengoma DS. Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania. Malar J. 2015;14:135.","journal-title":"Malar J"},{"issue":"8845","key":"6018_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0140-6736(93)90362-K","volume":"341","author":"TT Hien","year":"1993","unstructured":"Hien TT, White NJ. Qinghaosu. Lancet. 1993;341(8845):603\u20138.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"6018_CR15","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/0035-9203(94)90469-3","volume":"88","author":"TG Brewer","year":"1994","unstructured":"Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg. 1994;88(Suppl 1):S33\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6018_CR16","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015."},{"issue":"7572","key":"6018_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526(7572):207\u201311.","journal-title":"Nature"},{"issue":"5","key":"6018_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/INF.0000000000000306","volume":"33","author":"J Okebe","year":"2014","unstructured":"Okebe J, Bojang K, D\u2019Alessandro U. Use of artemisinin and its derivatives for the treatment of malaria in children. Pediatr Infect Dis J. 2014;33(5):522\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"6018_CR19","unstructured":"World Health Organization. Cluster on Communicable Diseases & WHO Consultation on Monitoring Antimalarial Drug Resistance. In: Monitoring antimalarial drug resistance : report of a WHO consultation. Geneva; 2002. 3. 5 December 2001. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/67590."},{"key":"6018_CR20","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria (archived)","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria (archived) 2003, Available from: https:\/\/www.who.int\/malaria\/publications\/atoz\/whohtmrbm200350\/en\/."},{"key":"6018_CR21","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Methods for surveillance of antimalarial drug efficacy 2009, Available from: https:\/\/www.who.int\/malaria\/publications\/atoz\/9789241597531\/en\/."},{"key":"6018_CR22","doi-asserted-by":"publisher","first-page":"f4040","DOI":"10.1136\/bmj.f4040","volume":"346","author":"P Sedgwick","year":"2013","unstructured":"Sedgwick P. Meta-analyses: heterogeneity and subgroup analysis. BMJ. 2013;346:f4040.","journal-title":"BMJ"},{"issue":"1","key":"6018_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12936-019-2848-1","volume":"18","author":"B Abuaku","year":"2019","unstructured":"Abuaku B, Duah-Quashie NO, Quaye L, Matrevi SA, Quashie N, Gyasi A, et al. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015\u20132017. Malar J. 2019;18(1):206.","journal-title":"Malar J"},{"key":"6018_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1475-2875-9-378","volume":"9","author":"IA Ayede","year":"2010","unstructured":"Ayede IA, Falade AG, Sowunmi A, Jansen FH. An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate\/sulphamethoxypyrazine\/pyrimethamine (fixed dose over 24 hours) versus artesunate\/amodiaquine (fixed dose over 48 hours). Malar J. 2010;9:378.","journal-title":"Malar J"},{"issue":"1","key":"6018_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17(1):144.","journal-title":"Malar J"},{"key":"6018_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12936-016-1381-8","volume":"15","author":"AM Dorkenoo","year":"2016","unstructured":"Dorkenoo AM, Yehadji D, Agbo YM, Layibo Y, Agbeko F, Adjeloh P, et al. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012\u20132013. Malar J. 2016;15:331.","journal-title":"Malar J"},{"key":"6018_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/1475-2875-11-338","volume":"11","author":"MA Dorkenoo","year":"2012","unstructured":"Dorkenoo MA, Barrette A, Agbo YM, Bogreau H, Kutoati S, Sodahlon YK, et al. Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005\u20132009. Malar J. 2012;11:338.","journal-title":"Malar J"},{"key":"6018_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1475-2875-6-146","volume":"6","author":"AM Kabanywanyi","year":"2007","unstructured":"Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar J. 2007;6:146.","journal-title":"Malar J"},{"key":"6018_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1475-2875-7-261","volume":"7","author":"R Kobbe","year":"2008","unstructured":"Kobbe R, Klein P, Adjei S, Amemasor S, Thompson WN, Heidemann H, et al. A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. Malar J. 2008;7:261.","journal-title":"Malar J"},{"key":"6018_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1475-2875-6-65","volume":"6","author":"D M\u00e9nard","year":"2007","unstructured":"M\u00e9nard D, Andrianina NNH, Ramiandrasoa Z, Randriamanantena A, Rasoarilalao N, Jahevitra M, et al. Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. Malar J. 2007;6:65.","journal-title":"Malar J"},{"key":"6018_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-7-237","volume":"7","author":"PF Mens","year":"2008","unstructured":"Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HDFH, et al. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malar J. 2008;7:237.","journal-title":"Malar J"},{"key":"6018_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12936-015-0918-6","volume":"14","author":"M Ndounga","year":"2015","unstructured":"Ndounga M, Pembe Issamou M, Casimiro PN, Koukouikila-Koussounda F, Bitemo M, Diassivy Matondo B, et al. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study. Malar J. 2015;14:423.","journal-title":"Malar J"},{"key":"6018_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1475-2875-13-309","volume":"13","author":"A Nhama","year":"2014","unstructured":"Nhama A, Bassat Q, Enosse S, Nhacolo A, Mutemba R, Carvalho E, et al. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique. Malar J. 2014;13:309.","journal-title":"Malar J"},{"issue":"12","key":"6018_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3855\/jidc.3058","volume":"7","author":"O Ojurongbe","year":"2013","unstructured":"Ojurongbe O, Lawal OA, Abiodun OO, Okeniyi JA, Oyeniyi AJ, Oyelami OA. Efficacy of artemisinin combination therapy for the treatment of uncomplicated falciparum malaria in Nigerian children. J Infect Dev Ctries. 2013;7(12):975\u201382.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"6018_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16(1):62.","journal-title":"Malar J"},{"issue":"8","key":"6018_CR36","doi-asserted-by":"publisher","first-page":"e6682","DOI":"10.1371\/journal.pone.0006682","volume":"4","author":"Z Premji","year":"2009","unstructured":"Premji Z, Umeh RE, Owusu-Agyei S, Esamai F, Ezedinachi EU, Oguche S, et al. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PLoS One. 2009;4(8):e6682.","journal-title":"PLoS One"},{"issue":"6","key":"6018_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1086\/591096","volume":"198","author":"M Ramharter","year":"2008","unstructured":"Ramharter M, Kurth F, Schreier AC, Nemeth J. Glasenapp iv, B\u00e9lard S, et al. fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis. 2008;198(6):911\u20139.","journal-title":"J Infect Dis"},{"issue":"11","key":"6018_CR38","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/infdis\/jit077","volume":"207","author":"P Sawa","year":"2013","unstructured":"Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, et al. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis. 2013;207(11):1637\u201345.","journal-title":"J Infect Dis"},{"key":"6018_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1475-2875-13-376","volume":"13","author":"A Shayo","year":"2014","unstructured":"Shayo A, Mandara CI, Shahada F, Buza J, Lemnge MM, Ishengoma DS. Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania. Malar J. 2014;13:376.","journal-title":"Malar J"},{"key":"6018_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1475-2875-8-48","volume":"8","author":"SB Sirima","year":"2009","unstructured":"Sirima SB, Tiono AB, Gansan\u00e9 A, Diarra A, Ou\u00e9draogo A, Konat\u00e9 AT, et al. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J. 2009;8:48.","journal-title":"Malar J"},{"issue":"3","key":"6018_CR41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-3156.2009.02222.x","volume":"14","author":"JI Thwing","year":"2009","unstructured":"Thwing JI, Odero CO, Odhiambo FO, Otieno KO, Kariuki S, Ord R, et al. In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated plasmodium falciparum malaria in western Kenya. Tropical Med Int Health. 2009;14(3):294\u2013300.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"6018_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1128\/AAC.04181-14","volume":"59","author":"MM Plucinski","year":"2015","unstructured":"Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, et al. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uige provinces, Angola. Antimicrob Agents Chemother. 2015;59(1):437\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"6018_CR43","volume-title":"Global database on antimalarial drug efficacy and resistance","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global database on antimalarial drug efficacy and resistance 2020. updated 24 January 2020. Available from: https:\/\/www.who.int\/malaria\/areas\/drug_resistance\/drug_efficacy_database\/en\/."},{"issue":"12","key":"6018_CR44","doi-asserted-by":"publisher","first-page":"e0225882","DOI":"10.1371\/journal.pone.0225882","volume":"14","author":"C Naing","year":"2019","unstructured":"Naing C, Whittaker MA, Htet NH, Aye SN, Mak JW. Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: a network meta-analysis. PLoS One. 2019;14(12):e0225882.","journal-title":"PLoS One"},{"issue":"1","key":"6018_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12936-017-1963-0","volume":"16","author":"S Whegang Youdom","year":"2017","unstructured":"Whegang Youdom S, Tahar R, Basco LK. Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis. Malar J. 2017;16(1):311.","journal-title":"Malar J"},{"key":"6018_CR46","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1038\/ncomms6606","volume":"5","author":"LC Okell","year":"2014","unstructured":"Okell LC, Cairns M, Griffin JT, Ferguson NM, Tarning J, Jagoe G, et al. Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun. 2014;5:5606.","journal-title":"Nat Commun"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-06018-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T10:08:54Z","timestamp":1617790134000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06018-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6018"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06018-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}